Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Oxford BioMedica Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Oxford BioMedica Plc, Medical Devices Deals, 2012 to YTD 2018 10
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Oxford BioMedica Acquires Windrush Court Office and Laboratory Facilities for USD5 Million 13
Partnerships 14
Boehringer Ingelheim, Imperial College London, University of Oxford, University of Edinburgh, Imperial Innovations, and Oxford BioMedica Enter into Collaboration Agreement 14
Oxford BioMedica Enters into Agreement with Cell Therapy Catapult, Stratophase and Synthace 16
Oxford BioMedica Enters into Agreement with Novartis 17
Oxford BioMedica Enters into Agreement with Green Cross 18
Oxford BioMedica Enters into Agreement with Novartis 19
Licensing Agreements 20
Axovant Sciences Enters into Licensing Agreement with Oxford BioMedica 20
Bioverativ Enters into Licensing Agreement with Oxford BioMedica 22
Orchard Therapeutics Expands Licensing Agreement with Oxford BioMedica 23
Oxford BioMedica Exercises Option for Licensing Agreement with GlaxoSmithKline 24
Oxford BioMedica Enters into Licensing Agreement with Novartis for LentiVector 25
Oxford BioMedica Amends Licensing Agreement With Sanofi 26
Oxford BioMedica Enters into Licensing Agreement with MolMed 27
Immune Design Licensing Agreement with Oxford BioMedica 28
Equity Offering 29
Oxford BioMedica to Raise USD28.4 Million in Private Placement of Shares 29
Oxford BioMedica Raises USD15.3 Million in Private Placement of Shares 30
Oxford BioMedica to Raise USD11.5 Million in Private Placement of Shares 32
Oxford BioMedica Raises USD33 Million in Private Placement of Shares 34
Oxford BioMedica Raises USD2.6 Million in Public Offering 36
Oxford BioMedica Completes Private Placement Of Shares For US$17 Million 37
Oxford BioMedica Completes Rights Offering Of Shares For US$1 Million 38
Oxford BioMedica Plc – Key Competitors 39
Oxford BioMedica Plc – Key Employees 40
Oxford BioMedica Plc – Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Recent Developments 42
Strategy And Business Planning 42
Sep 13, 2018: Oxford Biomedica announces further capacity expansion with new facility 42
Financial Announcements 43
Sep 13, 2018: Oxford Biomedica interim results for the six months ended 30 June 2018 43
Mar 15, 2018: Oxford Biomedica: Preliminary Results for the Year Ended 31 December 2017 49
Aug 17, 2017: Oxford Biomedica: Interim Results For The Six Months Ended 30 June 2017 59
Mar 16, 2017: Oxford Biomedica Announces Preliminary Results for the Year Ended 31 December 2016 64
Corporate Communications 65
Jul 02, 2018: Oxford BioMedica Announces Directorate Change 65
Jun 04, 2018: Oxford BioMedica Announces Directorate Change 66
Mar 15, 2018: Board Change: Oxford BioMedica Appoints Heather Preston as Non-Executive Director 67
Aug 29, 2017: Oxford BioMedica: Stuart Paynter starts as new Chief Financial Officer 68
Feb 28, 2017: Oxford BioMedica Appoints New Chief Financial Officer 69
Government and Public Interest 70
Jan 23, 2018: Oxford BioMedica announces £3 million grant awarded by Innovate UK 70
Other Significant Developments 71
Mar 28, 2018: Gyros Protein Technologies installs two Gyrolab xPlore systems at Oxford BioMedica for gene and cell therapy applications 71
Feb 14, 2018: The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day 72
Appendix 73
Methodology 73
About GlobalData 73
Contact Us 73
Disclaimer 73
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Oxford BioMedica Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Oxford BioMedica Plc, Deals By Therapy Area, 2012 to YTD 2018 9
Oxford BioMedica Plc, Medical Devices Deals, 2012 to YTD 2018 10
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Oxford BioMedica Acquires Windrush Court Office and Laboratory Facilities for USD5 Million 13
Boehringer Ingelheim, Imperial College London, University of Oxford, University of Edinburgh, Imperial Innovations, and Oxford BioMedica Enter into Collaboration Agreement 14
Oxford BioMedica Enters into Agreement with Cell Therapy Catapult, Stratophase and Synthace 16
Oxford BioMedica Enters into Agreement with Novartis 17
Oxford BioMedica Enters into Agreement with Green Cross 18
Oxford BioMedica Enters into Agreement with Novartis 19
Axovant Sciences Enters into Licensing Agreement with Oxford BioMedica 20
Bioverativ Enters into Licensing Agreement with Oxford BioMedica 22
Orchard Therapeutics Expands Licensing Agreement with Oxford BioMedica 23
Oxford BioMedica Exercises Option for Licensing Agreement with GlaxoSmithKline 24
Oxford BioMedica Enters into Licensing Agreement with Novartis for LentiVector 25
Oxford BioMedica Amends Licensing Agreement With Sanofi 26
Oxford BioMedica Enters into Licensing Agreement with MolMed 27
Immune Design Licensing Agreement with Oxford BioMedica 28
Oxford BioMedica to Raise USD28.4 Million in Private Placement of Shares 29
Oxford BioMedica Raises USD15.3 Million in Private Placement of Shares 30
Oxford BioMedica to Raise USD11.5 Million in Private Placement of Shares 32
Oxford BioMedica Raises USD33 Million in Private Placement of Shares 34
Oxford BioMedica Raises USD2.6 Million in Public Offering 36
Oxford BioMedica Completes Private Placement Of Shares For US$17 Million 37
Oxford BioMedica Completes Rights Offering Of Shares For US$1 Million 38
Oxford BioMedica Plc, Key Competitors 39
Oxford BioMedica Plc, Key Employees 40
Oxford BioMedica Plc, Other Locations 41
Oxford BioMedica Plc, Subsidiaries 41
List of Figures
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Oxford BioMedica Plc, Medical Devices Deals, 2012 to YTD 2018 10
【免責事項】
http://www.globalresearch.jp/disclaimer